The influence of gender on the aggravation of absence seizures by carbamazepine in the low-dose pentylenetetrazol rat model

Seizure

Volumn 13, Issue 4, 2004, Pages 208-216

  McLean, Karen J ^a   O'Brien, Terence J ^a,b   Cook, Mark J ^a   Vajda, Frank J E ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Absence seizures; Carbamazepine; Gender difference; Rat; Seizure aggravation

Indexed keywords

ALCOHOL; CARBAMAZEPINE; PENTETRAZOLE; POLYSORBATE 20; PROPYLENE GLYCOL;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ELECTRODE; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; FEMALE; FREQUENCY ANALYSIS; IMPLANTATION; LATENT PERIOD; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; SEX DIFFERENCE; SPIKE WAVE; STATISTICAL SIGNIFICANCE;

EID: 2342612714     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(03)00144-4     Document Type: Article

References (51)

1. Bauer, J. Seizure-inducing effects of antiepileptic drugs: a review. Acta Neurologica Scandanavica 1996; 94: 367-377.
2. Gram, L. and Dulac, O. Antiepileptic drug-induced worsening of seizures in adults and children. Epilepsia 1995; 36 (Suppl. 3): S57.
3. Lerman, P. Seizures induced or aggravated by anticonvulsants. Epilepsia 1986; 27: 706-710.
4. Perucca, E., Gram, L., Avanzini, G. and Dulac, O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998; 39: 5-17.
5. Mattson, R. H., Cramer, J. A., Collins, J. F. et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. The New England Journal of Medicine 1985; 313: 145-151.
6. Shorvon, S. The drug treatment of epilepsy. In: Epilepsy, 2nd edn. (Eds A. Hopkins, S. Shorvon and G. Cascino). London, Chapman & Hall, 1995: pp. 171-214.
7. Osorio, I., Reed, R. C. and Peltzer, J. N. Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine. Epilepsia 2000; 41: 887-894.
8. Micheletti, G., Vergnes, M., Marescaux, C. et al. Antiepileptic drug evaluation in a new animal model: spontaneous petit mal epilepsy in the rat. Arzneimittel-Forschung 1985; 35: 483-485.
9. Marescaux, C., Micheletti, G., Vergnes, M., Depaulis, A., Rumbach, L. and Warter, J. M. A model of chronic spontaneous petit mal-like seizures in the rat: comparison with pentylenetetrazol-induced seizures. Epilepsia 1984; 25: 326-331.
10. Cortez, M. A., McKerlie, C. and Snead, O. C. III. A model of atypical absence seizures: EEG, pharmacology, and developmental characterization. Neurology 2001; 56: 341-349.
11. Cook, M. J., Walker, J. and Tomblinson, E. B. Change in the type and pattern of seizures in patients with primary generalised epilepsy by treatment with carbamazepine. Journal of Clinical Neuroscience 1997; 4: 388.
12. Liporace, J. D., Sperling, M. R. and Dichter, M. A. Absence seizures and carbamazepine in adults. Epilepsia 1994; 35: 1026-1028.
13. Baykan, B., Gurses, C. and Gokyigit, A. Nose wiping: an unrecognized automatism in absence seizures. Clinical Electroencephalography 2000; 31: 157-159.
14. Genton, P. and McMenamin, J. Aggravation of seizures by antiepileptic drugs: what to do in clinical practice. Epilepsia 1998; 39 (Suppl. 3): S26-S29.
15. Panayiotopoulos, C. P., Chroni, E., Daskalopoulos, C., Baker, A., Rowlinson, S. and Walsh, P. Typical absence seizures in adults: clinical, EEG, video-EEG finding and diagnostic/syndromic considerations. Journal of Neurology, Neurosurgery, and Psychiatry 1992; 55: 1002-1008.
16. Callahan, D. J. and Noetzel, M. J. Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. Neurology 1992; 42: 2198-2201.
17. Backstrom, T., Gee, K. W., Lan, N., Sorensen, M. and Wahlstrom, G. Steroids in relation to epilepsy and anaesthesia. In: Steroids and Neuronal Activity (Eds D. Chadwick and K. Widdows). Ciba Foundation Symposium 153. Chichester, Wiley, 1990: pp. 225-230.
18. Snead, O. C. III, Depaulis, A., Vergnes, M. and Marescaux, C. Absence epilepsy: advances in experimental animal models. In: Jasper's Basic Mechanisms of the Epilepsies, 3rd edn.: Advances in Neurology, Vol. 79 (Eds A. V. Delgado-Escueta, W. A. Wilson, R. W. Olsen and R. J. Porter). Philadelphia, Lippincott Williams and Wilkins, 1999: pp. 253-278.
19. Depaulis, A., Snead, O. C. III, Marescaux, C. and Vergnes, M. Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents. Brain Research 1989; 498: 64-72.
20. Snead, O. C. III. Ganaxolone, a selective, high-affinity steroid modulator of the gamma-aminobutyric acid-A receptor, exacerbates seizures in animal models of absence. Annals of Neurology 1998; 44: 688-691.
21. Snead, O. C. III. The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges. Neuropharmacology 1991; 30: 161-167.
22. Kumaresan, S., David, J. and Joseph, T. Comparative profiles of sodium valproate and ethosuximide on electro-behavioural correlates in gamma-hydroxybutyrate and pentylenetetrazol induced absence seizures in rats. Indian Journal of Physiology and Pharmacology 2000; 44: 411-418.
23. Snead, O. C. III. Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures. European Journal of Pharmacology 1992; 213: 343-349.
24. Snead, O. C. III. Evidence for G protein modulation of experimental-generalized absence seizures in rat. Neuroscience Letters 1992; 148: 15-18.
25. Snead, O. C. III. Antiabsence seizure activity of specific GABAB and gamma-hydroxybutyric acid receptor antagonists. Pharmacology Biochemistry and Behavior 1996; 53: 73-79.
26. Freeman, M. E. The neuroendocrine control of the ovarian cycle of the rat. In: The Physiology of Reproduction, 2nd edn. (Eds E. Knobil and J. E. Neill). New York, Raven Press, 1994: pp. 613-658.
27. McLean, M. J., Taylor, C. P. and MacDonald, R. L. Phenytoin and carbamazepine limit sustained high frequency repetitive firing of action potentials of hippocampal neurons in cell culture and tissue slices. Society for Neuroscience Abstracts 1984; 10: 873.
28. Loiseau, P. Do antiepileptic drugs exacerbate seizures? Epilepsia 1998; 39: 2-4.
29. Snead, O. C. III. Basic mechanisms of generalized absence seizures. Annals of Neurology 1995; 37: 146-157.
30. Hosford, D. A. and Wang, Y. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia 1997; 38: 408-414.
31. Marescaux, C., Vergnes, M. and Depaulis, A. Genetic absence epilepsy in rats from Strasbourg - a review. Journal of Neural Transmission Supplementum 1992; 35: 37-69.
32. Richards, D. A., Morrone, L. A. and Bowery, N. G. Hippocampal extracellular amino acids and EEG spectral analysis in a genetic rat model of absence epilepsy. Neuropharmacology 2000; 39: 2433-2441.
33. Matejovska, I., Veliskova, J. and Velisek, L. Bicuculline-induced rhythmic EEG episodes: gender differences and the effects of ethosuximide and baclofen treatment. Epilepsia 1998; 39: 1243-1252.
34. Vergnes, M., Marescaux, C., Micheletti, G., Depaulis, A., Rumbach, L. and Warter, J. M. Enhancement of spike and wave discharges by GABAmimetic drugs in rats with spontaneous petit-mal-like epilepsy. Neuroscience Letters 1984; 44: 91-94.
35. Liu, Z., Vergnes, M., Depaulis, A. and Marescaux, C. Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat. Brain Research 1991; 545: 1-7.
36. A receptors in thalamic nuclei in lh/lh model of absences seizures. Epilepsy Research 1997; 27: 55-65.
37. Wallace, R. H., Marini, C., Petrou, S. et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nature Genetics 2001; 28: 49-52.
38. Kananura, C., Haug, K., Sander, T. et al. A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Archives of Neurology 2002; 59: 1137-1141.
39. Granger, P., Biton, B., Faure, C. et al. Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Molecular Pharmacology 1995; 47: 1189-1196.
40. Zhang, J. D. and Saito, K. Carbamazepine facilitates effects of GABA on rat hippocampus slices. Chung-Kuo Yao Li Hsueh Pao - Acta Pharmacologica Sinica 1997; 18: 230-233.
41. B receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders? European Journal of Pharmacology 1989; 166: 95-99.
42. Pryse-Phillips, W. E. and Jeavons, P. M. Effect of carbamazepine (Tegretol) on the electroencephalograph and ward behavior of patients with chronic epilepsy. Epilepsia 1970; 11: 263-273.
43. Dossi, R. C., Nunez, A. and Steriade, M. Electrophysiology of a slow (0.5-4 Hz) intrinsic oscillation of cat thalamocortical neurones in vivo. Journal of Physiology 1992; 447: 215-234.
44. Budziszewska, B., Van Luijtelaar, G., Coenen, A. M. L., Leskiewicz, M. and Lason, W. Effects of neurosteroids on spike-wave discharges in the genetic epileptic WAG/Rij rat. Epilepsy Research 1999; 33: 23-29.
45. Holmes, G. L., McKeever, M. and Adamson, M. Absence seizures in children: clinical and electroencephalographic features. Annals of Neurology 1987; 21: 268-273.
46. Jando, G., Carpi, D., Kandel, A. et al. Spike-and-wave epilepsy in rats: sex differences and inheritance of physiological traits. Neuroscience 1995; 64: 301-317.
47. Herzog, A. G., Klein, P. and Ransil, B. J. Three patterns of catamenial epilepsy. Epilepsia 1997; 38: 1082-1088.
48. A receptor function. Molecular Pharmacology 1994; 46: 977-985.
49. A receptor. Mechanism of action and physiological significance. Progress in Neurobiology 1992; 38: 379-395.
50. A receptor complex: the pharmacological properties and therapeutic potential of epalons. Critical Reviews in Neurobiology 1995; 9: 207-227.
51. Banerjee, P. K. and Snead, O. C. III. Neuroactive steroids exacerbate gamma-hydroxybutyric acid-induced absence seizures in rats. European Journal of Pharmacology 1998; 359: 41-48.